Navigation Links
Oclaro Reports Positive Adjusted EBITDA in First Post-Merger Quarter
Date:7/23/2009

s margin dilution from our acquisition of the Spectra-Physics laser diode business in exchange for our New Focus business, as we will be incurring additional costs while we transition related fabrication activities to Europe in the next 6 to 12 months.
  • Adjusted EBITDA of negative $6.0 million to breakeven.
  • The foregoing guidance is based on current expectations. These statements are forward looking, and actual results may differ materially. Please see the Safe Harbor Statement in this earnings release for a description of certain important risk factors that could cause actual results to differ, and refer to Oclaro, Inc's (formerly Bookham .Inc.) most recent annual and quarterly reports on file with the Securities and Exchange Commission (SEC) for a more complete description of the risks. Furthermore, our outlook excludes items that may be required by GAAP, including, but not limited to, restructuring and related costs, acquisition or disposal related costs, expenses or income from certain legal actions, settlements and related costs outside our normal course of business, impairments of other long-lived assets, extraordinary items, as well as the expensing of stock options and restricted stock grants under SFAS 123R.

    Conference Call

    Oclaro will report financial results for the fourth quarter of fiscal 2009 today at 2:00 p.m. PT/5:00 p.m. ET. To listen to the live conference call, please dial (480) 629-9643. A replay of the conference call will be available through July 30, 2009. To access the replay, dial (303) 590-3030. The conference code for the replay is 4116120. A webcast of this call will be available in the investors section of Oclaro's website at www.oclaro.com.

    About Oclaro

    Oclaro, Inc., with headquarters in San Jose, California, is a tier 1 provider of high performance optic
    '/>"/>

    SOURCE Oclaro, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

    Related medicine news :

    1. Oclaro Launches Eye-Safe High Power Laser Diodes at LASER 2009
    2. Hard to Treat Diseases, Inc. (HTDS) Reports on Ribavirin Research as Potential Treatment for MS
    3. Zimmer Holdings, Inc. Reports Second Quarter 2009 Financial Results
    4. Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance
    5. Digirad Corporation Reports Second Quarter 2009 Financial Results
    6. Affymetrix Reports Second Quarter 2009 Results
    7. Exponent Reports Second Quarter 2009 Results
    8. Endologix Reports 42% Second Quarter 2009 Revenue Growth
    9. Universal Health Realty Income Trust Reports 2009 Second Quarter Financial Results
    10. Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance
    11. Amylin Pharmaceuticals Reports Second Quarter Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2015)... Franklin, TN (PRWEB) , ... August 28, 2015 ... ... of recipients of the Veterans Award, honoring military veterans leading in business. ... 2015 honorees. , The inaugural Nashville Business Journal's 2015 Veterans Awards ...
    (Date:8/28/2015)... ... August 28, 2015 , ... Dr. Gregory K. Toumayan, D.C., Q.M.E., ... resulting in shoulder pain, hip pain, neck pain, stiffness, muscle spasms, and ... the University of Illinois, and then went on to earn his title of Doctor ...
    (Date:8/28/2015)... Rochester, NY (PRWEB) , ... August 28, 2015 , ... ... injectable, Kybella™. It is the first and only nonsurgical product approved by the ... Dr. Vito Quatela and Dr. William Koenig are among ...
    (Date:8/28/2015)... , ... August 28, 2015 , ... Mendon, IL, home ... good music and good people, all for a good cause. In its second year, ... sponsored once more by Best Drug Rehabilitation. The “Mission” of “Music With A Mission” ...
    (Date:8/28/2015)... , ... August 28, 2015 , ... ... evaluations for those seeking to go deep sea diving. The act of ... and decompression sickness; for these reasons, it is vital that all recreational and ...
    Breaking Medicine News(10 mins):Health News:MyGenetx Board Member Receives Veterans Award 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 3Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3Health News:Best Drug Rehabilitation Sponsors "Music With A Mission" Concert Featuring Avenue Beat 2Health News:Healthpointe Now Offering Scuba Physicals 2
    ... In response to the recent media attention on ... Williamsburg Place , one of the nation,s leading addiction treatment ... Omar S. Manejwala, M.D., Associate Medical Director for the Farley Center ... area and has appeared nationally recently on programs such as the ...
    ... WORCESTER, Mass., July 17 The Hanover Insurance Group (NYSE: ... announced the availability of a new product offering that can extend homeowners ... , , (Logo: ... The coverage is more important than ever as the population of people ...
    ... temperament, study finds , FRIDAY, July 17 (HealthDay News) -- ... may have nothing to do with your parenting skills because ... of brain activity may determine a child,s temperament, a new ... the DRD4 gene and activity in the frontal cortex of ...
    ... N.C., July 17 Rabies is a virus that occurs in mammals ... humans if it is not treated. Nearly 90 percent of cases occur ... occur in domestic animals like dogs or cats. Humans usually become infected ... , Early symptoms of rabies are fever, headache and ...
    ... , , , GLASGOW, ... the UK would most like to be the national emblem of England, ... comes from a new survey commissioned by AXA PPP healthcare,s Nutrition and ... the EU lifted its ban on the sale of ,misshapen, produce such ...
    ... The ... Partner at the law firm of Loeb & Loeb LLP, as Chair, and Sheldon Kwiat, President ... ... YAI/National Institute for People with Disabilities (YAI/NIPD) Board of Trustees has elected Eliot Green, a ...
    Cached Medicine News:Health News:Omar S. Manejwala, MD Speaks Out Nationally on Diprivan/Propofol Abuse 2Health News:Omar S. Manejwala, MD Speaks Out Nationally on Diprivan/Propofol Abuse 3Health News:The Hanover Launches New Insurance Option to Protect Family Members in Assisted Living Facilities 2Health News:The Hanover Launches New Insurance Option to Protect Family Members in Assisted Living Facilities 3Health News:Easy Baby or Fussy -- It May Be Out of Mom's Control 2Health News:Rabies: How to Protect Yourself and Your Pets 2Health News:Potato Tops Poll To Be UK's National Veg 2Health News:YAI/NIPD Board of Trustees Elects Eliot Green Chair and Sheldon Kwiat Vice Chair 2Health News:YAI/NIPD Board of Trustees Elects Eliot Green Chair and Sheldon Kwiat Vice Chair 3Health News:YAI/NIPD Board of Trustees Elects Eliot Green Chair and Sheldon Kwiat Vice Chair 4
    (Date:8/28/2015)... 28, 2015 Research and ... the "Investigation Report on China,s Ranibizumab Market, 2012-2019" ... Novartis, ranibizumab was approved by CFDA to treat wet ... Lucentis, a product of Novartis, is available in the ... self- developed drug for the treatment of wet AMD ...
    (Date:8/28/2015)...  IP Shakti, LLC, today announced that it has changed ... Logo - http://photos.prnewswire.com/prnh/20150827/261551LOGO ... identity signifies our transformation into a company focused on patent ... patent claim validity." ... Shield™ platform, the Company commenced a corporate re-branding initiative in ...
    (Date:8/28/2015)...  Perrigo Company plc ("Perrigo") (NYSE: PRGO ; ... of leading OTC brands from GSK in an all ... a clear demonstration of Perrigo,s unique ability to maximize ... spanning 36 countries.  Perrigo Chairman, President ... are excited to complete this transaction, which clearly demonstrates ...
    Breaking Medicine Technology:Investigation Report on China's Ranibizumab Market, 2012-2019 2IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4
    ... VacChina 2011 - - ... - - welcomes world class ... vaccine R&D and manufacturing technologies in China. The ... national regulatory authority of China -- the State Food and Drug ...
    ... Aug. 18, 2011 Generex Biotechnology Corporation (OTCBB: ... Company,s wholly-owned subsidiary Antigen Express, Inc. ( www.antigenexpress.com ... 2 trial with an off-the-shelf immunotherapeutic cancer vaccine, ... Healthtech Institute,s Sixth Annual ImVacS: The Immunotherapeutics and ...
    Cached Medicine Technology:VacChina 2011 - Bridging the China Vaccine Industry with the World Class Biotechnologies 2Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program 2Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program 3Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program 4
    ... III DLE (Drug List Editor) Multi-Channel Infusion ... infusion technology. The instrument combines three independent ... versatility in an unparalleled small size. Now ... III Infusion System simplifies the delivery of ...
    ... The Gemini Family of infusion ... with a collective series of ... product line offers a wide ... IV sets, each featuring the ...
    ... first steps any hospital or health system ... powerful, most effective tools available for physicians ... clinician documentation and electronic medical record (EMR) ... this goal. In fact, its the most ...
    ... specialty Eraser instruments have been designed ... the right tool for situations requiring ... series of 25 gauge intraocular, bipolar, ... treatment of target tissues for fine-tip ...
    Medicine Products: